Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ocular Hypertension (OH)”

Showing 13 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00845299
What this trial is testing

Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Who this might be right for
GlaucomaOcular Hypertension
Mati Therapeutics Inc. 40
Large-scale testing (Phase 3)Study completedNCT02822729
What this trial is testing

A Long-term Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution in Patients With OAG or OH: RENGE Study

Who this might be right for
Open Angle Glaucoma or Ocular Hypertension
Santen Pharmaceutical Co., Ltd. 125
Post-approval studies (Phase 4)Study completedNCT00647101
What this trial is testing

Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 600
Testing effectiveness (Phase 2)WithdrawnNCT00855517
What this trial is testing

The Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Who this might be right for
GlaucomaOcular Hypertension
Mati Therapeutics Inc.
Testing effectiveness (Phase 2)Study completedNCT01481051
What this trial is testing

A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Who this might be right for
GlaucomaOcular Hypertension (OH)
Mati Therapeutics Inc. 57
Large-scale testing (Phase 3)Study completedNCT01357616
What this trial is testing

Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Alcon Research 328
Post-approval studies (Phase 4)Study completedNCT01369771
What this trial is testing

The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma

Who this might be right for
Ocular HypertensionOpen-Angle Glaucoma
FinnMedi Oy 30
Post-approval studies (Phase 4)Study completedNCT05857267
What this trial is testing

Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Laboratorios Poen 84
Post-approval studies (Phase 4)Ended earlyNCT00047606
What this trial is testing

Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research 84
Large-scale testing (Phase 3)Ended earlyNCT00912054
What this trial is testing

DuoTrav APS Versus XALACOM® in Ocular Surface Health

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Alcon Research 240
Testing effectiveness (Phase 2)Study completedNCT01229982
What this trial is testing

A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Who this might be right for
Ocular HypertensionOpen Angle Glaucoma
Mati Therapeutics Inc. 121
Post-approval studies (Phase 4)Study completedNCT00143208
What this trial is testing

Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.

Who this might be right for
GlaucomaOcular Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 250
Testing effectiveness (Phase 2)Study completedNCT00821002
What this trial is testing

Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Mati Therapeutics Inc. 32

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation